Cubist Systematic Strategies, LLC Entrada Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.58 - $16.2 $35,972 - $60,831	3,755 Added 927.16%	4,160 $60,000
Q4 2022 Feb 14, 2023	SELL	$13.52 - $22.89 $8,112 - $13,734	-600 Reduced 59.7%	405 $5,000
Q3 2022 Nov 14, 2022	SELL	$9.65 - $15.76 $8,385 - $13,695	-869 Reduced 46.37%	1,005 $16,000
Q2 2022 Aug 15, 2022	BUY	$5.49 - $12.94 $10,288 - $24,249	1,874 New	1,874 $23,000
Q1 2022 May 16, 2022	SELL	$7.99 - $16.93 $88,609 - $187,753	-11,090 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.7 - $35.0 $151,933 - $388,150	11,090 New	11,090 $190,000

101

28.1M

34.5K

16.4K

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $556M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.